AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: ABT
Report Date: 2026-07-15
Full Report: https://amaly.io/stock/ABT

EXECUTIVE SUMMARY
------------------
Compliance Status: COMPLIANT
Quality Rating: AAA
Description: Abbott Laboratories (ABT), a leading healthcare company in the Medical - Devices industry, demonstrates strong Shariah compliance through low debt levels, minimal impermissible income, and permissible core business activities in diagnostics, nutrition, and medical devices. All major financial ratios pass AAOIFI, MSCI, and S&P thresholds, with inclusion in all key Shariah indices confirming overall compliance. Minor purification is required for trace interest income, but no disqualifying business activities or controversies impact status. ESG alignment is positive, with low risk in governance and human rights. This report provides a multi-perspective analysis affirming ABT as a viable Shariah-compliant investment.

Primary Compliance Concerns:
- Minor interest income (0.94%) requiring purification
- Limited transparency on subsidiary financing structures

Purification Requirement: 0.94%
Index Inclusion: Included in all major Shariah indices: S&P Dow Jones, MSCI Islamic, FTSE Shariah, and DJIM

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 5.9%
Liquidity Ratio: 3.0%
Interest Income Ratio: 0.0%
Purification Required: 0.94%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: INCLUDED
MSCI Islamic: INCLUDED
DJIM: INCLUDED
FTSE Shariah: INCLUDED
Total: 4 of 4
Last Verified: 2026-02-28

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q1 2026
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-05-11T12:00:00Z

---
Full interactive report: https://amaly.io/stock/ABT
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.